Release Date: 05/02/14 09:38 Summary: Notice that remaining conditions to takeover bid freed Price Sensitive: Yes Download Document 293.48KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%